| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.27 | 1e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 6e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.087 | 0.2 |